Loading... 2 0 5 0 false
Credit Name
Belinda Yeo
Full Name
Yeo, Belinda
 
 
Loading... 3 0 5 0 false

Publications

Results 1-20 of 22 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
15-Apr-2021Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer.Chidley, Phoebe; Foroudi, Farshad ; Tacey, Mark A ; Khor, Richard ; Yeh, Janice; Bevington, Elaine; Hyett, Anthony; Loh, Su Wen; Chew, Grace ; McCracken, James; Neoh, Derek E ; Yeo, Belinda ; Baker, Caroline; Jassal, Sunil; Law, Michael; Zantuck, Natalie; Cokelek, Margaret; Guerrieri, Mario; Brown, Belinda; Stoney, David; Ng, Michael; Chao, Michael 
210-Feb-2021The IHC4+C score: an affordable and reproducible non-molecular decision-aid in hormone receptor-positive breast cancer. Does it still hold value for patients in 2020?Harel, Nadav; Cheema, Steven ; Williams, David S ; Ireland-Jenkin, Kerryn ; Fancourt, Tineke ; Dodson, Andrew; Yeo, Belinda 
3Jan-2021CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care.Hui, Rina; de Boer, Richard; Lim, Elgene; Yeo, Belinda ; Lynch, Jodi
4Dec-2020Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer.Conduit, C; de Boer, R H; Lok, S; Gibbs, P; Malik, L; Loh, Zoe ; Yeo, Belinda ; Greenberg, S; Devitt, B; Lombard, J; Nottage, M; Collins, I; Torres, J; Nolan, M; Nott, L
511-Nov-2020Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost?Bromley, Luke; Xu, Jennifer; Loh, Su-Wen; Chew, Grace ; Lau, Eddie ; Yeo, Belinda 
6Nov-2020"First Do No Harm": Significance of Delays from Diagnosis to Surgery in Patients with Non-metastatic Breast Cancer.Xu, Jennifer; Bromley, Luke; Chew, Grace ; Yeo, Belinda 
7Nov-2020Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.Kanjanapan, Yada; Lok, Sheau Wen; Gibbs, Peter; De Boer, Richard; Yeo, Belinda ; Greenberg, Sally; Barnett, Frances; Knott, Louise; Richardson, Gary; Wong, Rachel; Nottage, Michelle; Collins, Ian M; Torres, Javier; Lombard, Janine; Johns, Julie; Harold, Michael; Malik, Laeeq
8Nov-2020Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer.de Boer, Richard; Hui, Rina; Lim, Elgene; Yeo, Belinda ; Zdenkowski, Nicholas
94-Jun-2020Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.Murphy, Alexandra C ; Koshy, Anoop N ; Cameron, William; Horrigan, Mark ; Kearney, Leighton; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B 
105-Mar-2020Tracking Drug-Induced Epithelial-Mesenchymal Transition in Breast Cancer by a Microfluidic Surface-Enhanced Raman Spectroscopy Immunoassay.Zhang, Zhen; Wang, Jing; Shanmugasundaram, Karthik Balaji; Yeo, Belinda ; Möller, Andreas; Wuethrich, Alain; Lin, Lynlee L; Trau, Matt
112-Mar-2020Efficacy of mobile health cardiovascular risk-reduction strategies in cancer survivors.Murphy, Alexandra C ; Koshy, Anoop N ; Mousley, Johanna; Meehan, Georgina; Kunniardy, Phelia; Clark, David J ; Kearney, Leighton G ; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B 
1223-Sep-2019Early enrichment of ESR1 mutations and the impact on gene expression in pre-surgical primary breast cancer treated with aromatase inhibitors.Leal, Mariana F; Haynes, Benjamin P; Schuster, Eugene F; Yeo, Belinda ; Afentakis, Maria; Zabaglo, Lila; Martins, Vera; Buus, Richard; Dodson, Andrew; Cheang, Maggie C U; Smith, Ian E; Martin, Lesley-Ann; Dowsett, Mitch
131-Jul-2019Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer.Cheung, Yee-Ming; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis 
14Mar-2019A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.Lok, Sheau W; Whittle, James R; Vaillant, François; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria João; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Bujak, Andjelija Zivanovic; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J
152019The effects of adjuvant endocrine therapy on bone health in women with breast cancer.Ramchand, Sabashini K ; Cheung, Yee-Ming; Yeo, Belinda ; Grossmann, Mathis 
162019Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.Lopez-Knowles, Elena; Pearson, Alex; Schuster, Gene; Gellert, Pascal; Ribas, Ricardo; Yeo, Belinda ; Cutts, Ros; Buus, Richard; Garcia-Murillas, Isaac; Haynes, Ben; Martin, Lesley-Ann; Smith, Ian; Turner, Nick; Dowsett, Mitch
172019Ectopic breast cancer in the inguinal region.Loh, Zoe ; Yeo, Belinda ; Williams, David S ; Gyorki, David E
185-Dec-2018A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer.Lindeman, Geoffrey J; Lok, Sheau Wen; Whittle, James R; Vaillant, Francois; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria J; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Zivanovic Bujak, Andjelija; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E
194-Sep-2018Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.Buus, Richard; Yeo, Belinda ; Brentnall, Adam R; Klintman, Marie; Cheang, Maggie Chon U; Khabra, Komel; Sestak, Ivana; Gao, Qiong; Cuzick, Jack; Dowsett, Mitch
20Apr-2018The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.Yeo, Belinda ; Redfern, Andrew D; Mouchemore, Kellie A; Hamilton, John A; Anderson, Robin L